Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

This study has been completed.

Study NCT00093002 Information provided by AstraZeneca

First Received: September 28, 2004 Last Updated: June 11, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2007
Estimated Primary Completion Date:	No date given